Khalaf Kristin M, Coyne Karin S, Globe Denise R, Armstrong Edward P, Malone Daniel C, Burks Jack
Allergan, Inc, Irvine, CA, USA (KMK, DRG); Evidera, Bethesda, MD, USA (KSC); University of Arizona College of Pharmacy, Tucson, AZ, USA (KMK, EPA, DCM); and Florida International University, Miami, FL, USA (JB). Dr. Khalaf is now with Xcenda, Palm Harbor, FL, USA. Dr. Globe is now with Novartis Pharmaceuticals, East Hanover, NJ, USA.
Int J MS Care. 2015 Jan-Feb;17(1):14-25. doi: 10.7224/1537-2073.2013-040.
This study was conducted to assess self-reported prevalence and management of lower urinary tract symptoms (LUTS), along with drivers of treatment seeking, among patients with multiple sclerosis (MS).
An online, cross-sectional survey was administered to US-residing participants with self-reported MS to assess presence of LUTS, including urinary incontinence (UI). Participants experiencing LUTS were asked additional questions related to management and current therapies. Multivariate logistic regression identified drivers of treatment-seeking behavior.
A total of 1052 participants completed the survey; 1047 were included in the analysis. Nine hundred sixty-six participants (92%) reported at least one LUTS, the most common being post-micturition dribble (64.9%), urinary urgency (61.7%), and a feeling of incomplete emptying (60.7%). Eight hundred twenty-six (79%) reported having some type of UI. Of those with any type of LUTS, 70% (n = 680) had previously discussed urinary symptoms with a health-care provider (HCP), while only 32% (n = 311) had seen an HCP in the past year. Logistic regression found urgency (odds ratio [OR] 1.20 [95% confidence interval (CI), 1.00-1.44]), intermittent urine stream (OR 1.40 [95% CI, 1.15-1.69]), and urgency UI (OR 1.78 [95% CI, 1.22-2.60]) to be significant predictors of seeking treatment. Of those who had discussed LUTS with an HCP, 480 (70.6%) were currently receiving at least one LUTS treatment; the most common treatments were reducing fluid intake, pelvic exercises, oral anticholinergic medications, and avoiding certain foods/alcohol.
LUTS are commonly experienced among people with MS but are largely untreated. Proper LUTS assessment and work-up is warranted in MS patients.
本研究旨在评估多发性硬化症(MS)患者自我报告的下尿路症状(LUTS)患病率及管理情况,以及寻求治疗的驱动因素。
对居住在美国且自我报告患有MS的参与者进行了一项在线横断面调查,以评估LUTS的存在情况,包括尿失禁(UI)。经历LUTS的参与者被问及与管理和当前治疗相关的其他问题。多因素逻辑回归确定了寻求治疗行为的驱动因素。
共有1052名参与者完成了调查;1047名被纳入分析。966名参与者(92%)报告至少有一种LUTS,最常见的是排尿后滴沥(64.9%)、尿急(61.7%)和排尿不尽感(60.7%)。826名(79%)报告有某种类型的UI。在有任何类型LUTS的患者中,70%(n = 680)曾与医疗保健提供者(HCP)讨论过泌尿症状,而过去一年中只有32%(n = 311)看过HCP。逻辑回归发现尿急(优势比[OR] 1.20 [95%置信区间(CI),1.00 - 1.44])、间歇性尿流(OR 1.40 [95% CI,1.15 - 1.69])和尿急性UI(OR 1.78 [95% CI,1.22 - 2.60])是寻求治疗的显著预测因素。在与HCP讨论过LUTS的患者中,480名(70.6%)目前至少接受一种LUTS治疗;最常见的治疗方法是减少液体摄入、盆底肌锻炼、口服抗胆碱能药物以及避免某些食物/酒精。
LUTS在MS患者中很常见,但大多未得到治疗。MS患者有必要进行适当的LUTS评估和检查。